Effective July 1, 2022, Part A pharmacists, pharmacy technicians, registered pharmacy students, and interns are authorized to perform certain point-of-care tests (POCTs) for the purpose of assisting patients with the management of their medication(s) to treat chronic disease. This authority is enabled through regulatory amendments to the following regulations:


The POCTs included within this scope are:

  • Glucose
  • Hemoglobin A1C (HbA1C)
  • Lipids
  • Prothrombin time and International Normalized Ratio (PT/INR)

It is important to note that the interpretation of the test results must be performed by a Part A pharmacist.


To support pharmacy professionals with the implementation of point-of-care testing services, OPA has created the following resources/tools:

While point-of-care testing by pharmacy professionals is currently not publicly funded, OPA continues to work with the Ministry to emphasize the value of this service and will provide updates to pharmacy professionals should there be any changes.


Additional Resources: